These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27626707)

  • 1. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
    Horne GA; Copland M
    Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery approaches to target Wnt signaling in cancer stem cells.
    Curtin JC; Lorenzi MV
    Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
    Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
    Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
    Shimizu T; Nakagawa K
    Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
    Oren O; Smith BD
    Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2011 Mar; 31(3):893-6. PubMed ID: 21498710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways.
    An SM; Ding Q; Zhang J; Xie J; Li L
    Sci China Life Sci; 2014 Jun; 57(6):575-80. PubMed ID: 24829106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
    Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).
    Kharkar PS
    Expert Opin Ther Pat; 2017 Jul; 27(7):753-761. PubMed ID: 28460551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.
    Beyer C; Dees C; Distler JH
    Arch Dermatol Res; 2013 Jan; 305(1):1-8. PubMed ID: 23208311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.
    Justilien V; Fields AP
    Clin Cancer Res; 2015 Feb; 21(3):505-13. PubMed ID: 25646180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling as potential therapeutic target in lung cancer.
    Yang J; Chen J; He J; Li J; Shi J; Cho WC; Liu X
    Expert Opin Ther Targets; 2016 Aug; 20(8):999-1015. PubMed ID: 26882052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.